Showing results (351-360 of 389) with videos related to
Sort By:
Pageof 39
ERJ Open Research|February 18, 2026
Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)Kazuya Tsubouchi, Masayuki Hirose, Reoto Takei, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Incidence of B cell malignancies in patients with lung cancer receiving PD-1 blockade therapyToshifumi Ninomiya, Caiyang Fang, Hirofumi Hamano, et al.Clinical Lung Cancer|January 3, 2026
Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424LShunichi Kataoka, Takehito Shukuya, Hiroshi Ohtsu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2017
Alectinib for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)Eiji Iwama, Yasushi Goto, Haruyasu Murakami, et al.Nature Communications|March 23, 2025
Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLCKentaro Tanaka, Jun Sugisaka, Yoshimasa Shiraishi, et al.Lung Cancer (Amsterdam, Netherlands)|July 23, 2024
Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)Daichi Fujimoto, Hidetoshi Hayashi, Kenta Murotani, et al.Molecular Cancer|October 29, 2025
IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancerRitsu Ibusuki, Eiji Iwama, Atsushi Shimauchi, et al.Science Translational Medicine|December 14, 2022
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancerKentaro Tanaka, Kenji Chamoto, Sho Saeki, et al.European Journal of Cancer (Oxford, England : 1990)|March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMAJordi Remon, Benjamin Lacas, Roy Herbst, et al.BMC Pulmonary Medicine|November 7, 2024
Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registryTomotsugu Takano, Kazuya Tsubouchi, Naoki Hamada, et al.Pageof 39